Celltrion Signs Exclusive Supply Deals for Omlyclo and Aptozma in the US
Predicted impact: Medium
US exclusive supply deals for two biosimilars; contract size not disclosed, likely meaningful for revenue.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.